Published in J Innate Immun on November 03, 2016
New and emerging roles for mast cells in host defence. Curr Opin Immunol (2006) 1.88
Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells. J Immunol (2003) 1.71
The development of early host response to Pseudomonas aeruginosa lung infection is critically dependent on myeloid differentiation factor 88 in mice. J Biol Chem (2004) 1.58
Enhancement of mast cell IL-6 production by combined toll-like and nucleotide-binding oligomerization domain-like receptor activation. Int Arch Allergy Immunol (2010) 1.40
Public awareness and use of direct-to-consumer genetic tests: results from 3 state population-based surveys, 2006. Am J Public Health (2008) 1.15
Bone marrow-derived hemopoietic precursors commit to the T cell lineage only after arrival in the thymic microenvironment. J Immunol (2007) 1.15
Development of an interleukin-12-deficient mouse model that is permissive for colonization by a motile KE26695 strain of Helicobacter pylori. Infect Immun (2003) 1.15
Prostaglandin E2 induces degranulation-independent production of vascular endothelial growth factor by human mast cells. J Immunol (2004) 1.13
Dengue virus selectively induces human mast cell chemokine production. J Virol (2002) 1.12
A critical role for mast cells and mast cell-derived IL-6 in TLR2-mediated inhibition of tumor growth. J Immunol (2010) 1.10
IgE-mediated mast cell activation induces Langerhans cell migration in vivo. J Immunol (2004) 1.10
Mast cells have a pivotal role in TNF-independent lymph node hypertrophy and the mobilization of Langerhans cells in response to bacterial peptidoglycan. J Immunol (2006) 1.07
Disruption of the chemokine-like receptor-1 (CMKLR1) gene is associated with reduced adiposity and glucose intolerance. Endocrinology (2011) 1.05
Human mast cell activation with virus-associated stimuli leads to the selective chemotaxis of natural killer cells by a CXCL8-dependent mechanism. Blood (2008) 1.03
Curcumin causes superoxide anion production and p53-independent apoptosis in human colon cancer cells. Cancer Lett (2010) 1.03
Connecting reovirus oncolysis and Ras signaling. Cell Cycle (2005) 1.02
Dengue virus infection of mast cells triggers endothelial cell activation. J Virol (2010) 1.02
Fungal zymosan induces leukotriene production by human mast cells through a dectin-1-dependent mechanism. J Allergy Clin Immunol (2006) 1.01
Curcumin-induced apoptosis in ovarian carcinoma cells is p53-independent and involves p38 mitogen-activated protein kinase activation and downregulation of Bcl-2 and survivin expression and Akt signaling. Mol Carcinog (2010) 0.98
Mast cells, histamine, and IL-6 regulate the selective influx of dendritic cell subsets into an inflamed lymph node. J Immunol (2010) 0.98
Zymosan treatment of mouse mast cells enhances dectin-1 expression and induces dectin-1-dependent reactive oxygen species (ROS) generation. Immunobiology (2008) 0.95
RNA sensors enable human mast cell anti-viral chemokine production and IFN-mediated protection in response to antibody-enhanced dengue virus infection. PLoS One (2012) 0.95
A dominant role for FcgammaRII in antibody-enhanced dengue virus infection of human mast cells and associated CCL5 release. J Leukoc Biol (2006) 0.95
Curcumin induces apoptosis in HCT-116 human colon cancer cells in a p21-independent manner. Exp Mol Pathol (2008) 0.93
TRAF6 specifically contributes to FcepsilonRI-mediated cytokine production but not mast cell degranulation. J Biol Chem (2008) 0.89
Dramatic caspase-dependent apoptosis in antibody-enhanced dengue virus infection of human mast cells. J Leukoc Biol (2008) 0.89
Aging in the absence of TLR2 is associated with reduced IFN-gamma responses in the large intestine and increased severity of induced colitis. J Leukoc Biol (2008) 0.89
Virus stimulation of human mast cells results in the recruitment of CD56⁺ T cells by a mechanism dependent on CCR5 ligands. FASEB J (2011) 0.87
Selective early production of CCL20, or macrophage inflammatory protein 3alpha, by human mast cells in response to Pseudomonas aeruginosa. Infect Immun (2003) 0.85
Subproteomic analysis of metal-interacting proteins in human B cells. Proteomics (2005) 0.84
Zebrafish mast cells possess an FcɛRI-like receptor and participate in innate and adaptive immune responses. Dev Comp Immunol (2010) 0.83
MAPK kinase 3 is a tumor suppressor with reduced copy number in breast cancer. Cancer Res (2013) 0.83
Mast cells and IgE activation do not alter the development of oral tolerance in a murine model. J Allergy Clin Immunol (2012) 0.81
Tissue eosinophilia in a mouse model of colitis is highly dependent on TLR2 and independent of mast cells. Am J Pathol (2010) 0.81
The gut microbiota of toll-like receptor 2-deficient mice exhibits lineage-specific modifications. Environ Microbiol Rep (2009) 0.80
Human mast cells induce caspase-independent DNA fragmentation in leukemic T cells. Oncol Rep (2003) 0.80
Predictors of interleukin-33 and thymic stromal lymphopoietin levels in cord blood. Pediatr Allergy Immunol (2015) 0.80
Local and systemic immunological parameters associated with remission of asthma symptoms in children. Allergy Asthma Clin Immunol (2012) 0.79
Transcription factors down-stream of Ras as molecular indicators for targeting malignancies with oncolytic herpes virus. Mol Oncol (2009) 0.79
Signal transducer and activator of transcription 4 (STAT4), but not IL-12 contributes to Pseudomonas aeruginosa-induced lung inflammation in mice. Immunobiology (2008) 0.79
Pro-oncogenic cell signaling machinery as a target for oncolytic viruses. Curr Pharm Biotechnol (2012) 0.77
Human mast cell activation with viruses and pathogen products. Methods Mol Biol (2015) 0.75
Air Pollution During Pregnancy and Cord Blood Immune System Biomarkers. J Occup Environ Med (2016) 0.75
Quantitative temporal in vivo proteomics (QTiPs) deciphers the transition of virus-driven myeloid cells into M2 macrophages. J Proteome Res (2017) 0.75
Keystone symposium on 'Mast cells, Basophils and IgE: host defense and disease'. Expert Rev Clin Immunol (2007) 0.75